Deutsch English Français

Contact

EP1074545

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1074545

EP1074545 - ISOQUINOLINESULFONAMIDE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 18.06.2004 Database last updated on 23.04.2024
Most recent event Tooltip	18.06.2004	Application deemed to be withdrawn	published on 04.08.2004 [2004/32]
Applicant(s)	For all designated states Hidaka, Hiroyoshi 3-A, 607 Otokikiyama, Tenpaku-ku Nagoya-shi Aichi 468-0063 / JP
	[N/P]
Former [2001/06]	For all designated states Hidaka, Hiroyoshi 3-A, 607 Otokikiyama, Tenpaku-ku Nagoya-shi, Aichi 468-0063 / JP
Inventor(s)	01 / HIDAKA, Hiroyoshi 607, Otokikiyama Tempaku-ku Nagoya-shi Aichi 468-0063 / JP
	02 / MURAMATSU, Hiroshi 27-10, Nishihirayama 5-chome Hino-shi Tokyo 191-0055 / JP
	[2001/06]
Representative(s)	Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastrasse 30 81925 München / DE
	[N/P]
Former [2001/06]	HOFFMANN - EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE
Application number, filing date	98917644.1	23.04.1998
	[2001/06]
	WO1998JP01868
Filing language	JA
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9954306
	Date:	28.10.1999
	Language:	EN
	[1999/43]
	Type:	A1 Application with search report
	No.:	EP1074545
	Date:	07.02.2001
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 28.10.1999 takes the place of the publication of the European patent application.
	[2001/06]
Search report(s)	International search report - published on:	JP	28.10.1999
	(Supplementary) European search report - dispatched on:	EP	11.07.2001
Classification	IPC:	C07D217/02, C07D217/24, C07D401/12, A61K31/495, A61K31/55, C08G64/14	[2001/34]
	CPC:	C07D401/12 (EP); A61P31/12 (EP); A61P31/18 (EP); A61P37/04 (EP); C07D217/02 (EP); C07D217/04 (EP); (+) C07D217/24 (EP) (-)
	Former IPC [2001/06]	C07D217/02, C07D217/24, C07D401/12, A61K31/495, A61K31/55
Designated contracting states	AT, BE, CH, DE, ES, FR, GB, IT, LI, NL, SE [2001/06]
Title	German:	ISOCHINOLINSULFONAMID-DERIVATE UND SIE ALS AKTIVEN BESTANDTEIL ENTHALTENDE MEDIKAMENTE	[2001/06]
	English:	ISOQUINOLINESULFONAMIDE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT	[2001/06]
	French:	DERIVES ISOQUINOLINESULFONAMIDE ET MEDICAMENTS INTEGRANT CES DERIVES COMME PRINCIPE ACTIF	[2001/06]
Entry into regional phase	16.10.2000	Translation filed
	30.10.2000	National basic fee paid
	30.10.2000	Search fee paid
	30.10.2000	Designation fee(s) paid
	30.10.2000	Examination fee paid
Examination procedure	28.10.1999	Request for preliminary examination filed International Preliminary Examining Authority: JP
	16.10.2000	Amendment by applicant (claims and/or description)
	30.10.2000	Examination requested [2001/06]
	17.09.2003	Despatch of a communication from the examining division (Time limit: M04)
	28.01.2004	Application deemed to be withdrawn, date of legal effect [2004/32]
	02.03.2004	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2004/32]
Fees paid	Renewal fee
	27.11.2000	Renewal fee patent year 03
	23.04.2001	Renewal fee patent year 04
	23.04.2002	Renewal fee patent year 05
	29.04.2003	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	27.11.2000	03 M06 Fee paid on 27.11.2000
	30.04.2004	07 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]US5733904 (FUJII YOICHI [JP], et al) [X] 1-8 * columns 2-3; claims 1,3 *;
		[X]EP0061673 (ASAHI CHEMICAL IND [JP], et al) [X] 1,2,5,6 * page 10, line 1 - page 11, line 29; claim 1 * * page 18, paragraph 3 *;
		[X]WO9806433 (YOSHITOMI PHARMACEUTICAL [JP], et al) [X] 1-8 * the whole document *;
		EP0956865 [ ] (YOSHITOMI PHARMACEUTICAL [JP]) [ ] * page 8, paragraphs 17,18 * * page 17; examples 204-221 * * page 18; examples 222-226,241-249,264-272 *
		[X] - SATO T ET AL, "INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REPLICATION BY A BIOAVAILABLE SERINE/THREONINE KINASE INHIBITOR, FASUDIL HYDROCHLORIDE", AIDS RESEARCH AND HUMAN RETROVIRUSES,NEW YORK, NY,US, (19980301), vol. 14, no. 4, ISSN 0889-2229, pages 293 - 298, XP000999983 [X] 1-8 * the whole document *
	International search	[X]JPS57156463 (ASAHI CHEMICAL IND, et al);
		[X]JPS58121279 (ASAHI CHEMICAL IND, et al);
		[X]JPS61152658 (ASAHI CHEMICAL IND, et al);
		[X]JPS61227581 (ASAHI CHEMICAL IND, et al);
		[X]JPS61293914 (HIDAKA HIROYOSHI);
		[X]JPH02256617 (ASAHI CHEMICAL IND)

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p